Otrexup

Active Ingredient(s): Methotrexate
FDA Approved: * October 11, 2013
Pharm Company: * ANTARES PHARMA, INC.
Category: Cancer

Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune-system suppressant.[4] It is used to treat cancer, autoimmune diseases, and ectopic pregnancy and for medical abortions.[4] Types of cancers it is used for include breast cancer, leukemia, lung cancer, lymphoma, gestational trophoblastic disease, and osteosarcoma.[4] Types of autoimmune diseases it is used for include psoriasis, rheumatoid arthritis, and Crohn... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Otrexup 12.5 mg/.4ml Subcutaneous Injection, Solution
NDC: 54436-012
Labeler:
Antares Pharma, Inc.
Otrexup 17.5 mg/.4ml Subcutaneous Injection, Solution
NDC: 54436-017
Labeler:
Antares Pharma, Inc.
Otrexup 22.5 mg/.4ml Subcutaneous Injection, Solution
NDC: 54436-022
Labeler:
Antares Pharma, Inc.
Otrexup 10 mg/.4ml Subcutaneous Injection, Solution
NDC: 82497-010
Labeler:
Otter Pharmaceuticals, LLC
Otrexup 12.5 mg/.4ml Subcutaneous Injection, Solution
NDC: 82497-012
Labeler:
Otter Pharmaceuticals, LLC
Otrexup 15 mg/.4ml Subcutaneous Injection, Solution
NDC: 82497-015
Labeler:
Otter Pharmaceuticals, LLC
Otrexup 17.5 mg/.4ml Subcutaneous Injection, Solution
NDC: 82497-017
Labeler:
Otter Pharmaceuticals, LLC
Otrexup 20 mg/.4ml Subcutaneous Injection, Solution
NDC: 82497-020
Labeler:
Otter Pharmaceuticals, LLC
Otrexup 22.5 mg/.4ml Subcutaneous Injection, Solution
NDC: 82497-022
Labeler:
Otter Pharmaceuticals, LLC
Otrexup 25 mg/.4ml Subcutaneous Injection, Solution
NDC: 82497-025
Labeler:
Otter Pharmaceuticals, LLC
More Results

Related Brands

Drugs with the same active ingredients

Popular Topics

otrexup

is any available...